Fairhaven Wealth Management’s CVS Health CVS Stock Holding History

Fairhaven Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$245K	Sell	2,630 -6	-0.2%	-$579	0.1%	87
2022 Q3	$251K	Buy	2,636 +6	+0.2%	+$594	0.11%	82
2022 Q2	$244K	Sell	2,630 -69	-3%	-$6.73K	0.11%	85
2022 Q1	$273K	Buy	2,699 +102	+4%	+$10.7K	0.11%	91
2021 Q4	$268K	Buy	2,597 +1	+0%	+$92	0.1%	85
2021 Q3	$220K	Buy	2,596 +2	+0.1%	+$168	0.09%	98
2021 Q2	$216K	Buy	+2,594	New	+$212K	0.09%	104
2019 Q1	–	Sell	-3,068	Closed	-$201K	–	84
2018 Q4	$201K	Buy	+3,068	New	+$229K	0.2%	72

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fairhaven Wealth Management's CVS Position: Q4 2022 in Review

Fairhaven Wealth Management reduced its CVS Health (CVS) stake by 0.23% in Q4 2022, selling an estimated $579 and leaving 2,630 shares worth $245K. The position accounts for 0.1% of the portfolio, ranked #87.

Fairhaven Wealth Management first reported a position in CVS in Q4 2018 and has held it in 8 quarters since. The position peaked at $273K in Q1 2022. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

Fairhaven Wealth Management held 2,630 shares of CVS Health worth $245K as of Q4 2022.
Fairhaven Wealth Management sold 6 CVS Health shares in Q4 2022, an estimated $579.
CVS Health made up 0.1% of Fairhaven Wealth Management's portfolio in Q4 2022, its #87 holding.
Fairhaven Wealth Management first reported a position in CVS Health in Q4 2018 and has held it in 8 quarters since.
Fairhaven Wealth Management's CVS Health position peaked at $273K in Q1 2022.
2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Fairhaven Wealth Management's 13F filing for Q4 2022, filed 10 Feb 2023.